InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Ouzren Nawal, 董事. Insider active across 1 company, notably Arena Pharmaceuticals INC. Aggregated, 2 filings have been published. History available since 11 June 2021. The latest transaction was disclosed on 11 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ouzren Nawal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
890 股Common StockSEC:0001628280-22-005906:0
3,067 股0Common StockSEC:0001628280-21-012280:0
2 条申报中的 2 条
About Ouzren Nawal
Nawal Ouzren serves as a Director at ARENA PHARMACEUTICALS INC. She contributes to the company's governance and strategic decision-making. Her experience in the pharmaceutical sector is valuable to the board.
